Read more

March 05, 2022
1 min read
Save

City of Hope receives $4.9M for basic stem cell research

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

City of Hope received a $4.9 million grant from California Institute for Regenerative Medicine.

The funding will help train the next generation of scientific leaders in stem cell research and its translation into novel lifesaving treatments.

StemCells
Source: Adobe Stock.

The 5-year grant will be used to mentor junior scientists with the help of City of Hope’s Irell & Manella Graduate School of Biological Sciences at Beckman Research Institute.

The grants will fund laboratory research and help scientists learn how to implement cell-based therapies, engineer and manufacture cells, obtain regulatory approval and commercialize biomedical products.

California Institute for Regenerative Medicine (CIRM), a state-funded agency, has awarded more than $121 million in grants to Beckman Research Institute at City of Hope.

“Our mission is to train predoctoral and postdoctoral CIRM scholars in basic stem cell and developmental biology, and the translation of this foundational knowledge into novel and effective therapies for patients with cancers, degenerative diseases, genetically caused conditions and other maladies,” Michael Barish, PhD, professor in the department of stem cell biology and regenerative medicine and program director of the CIRM-funded educational project, said in a press release.

Because of the program’s proximity to patient care areas, students also will have the chance to receive mentorship from City of Hope’s department of supportive care medicine and division of health equities.

Nadia Carlesso, MD, PhD
Nadia Carlesso

“This program originates from City of Hope’s longstanding expertise in conducting clinical trials and applying fundamental stem cell biology and gene therapy to the treatment of diseases,” Nadia Carlesso, MD, PhD, professor and chair of the department of stem cell biology and regenerative medicine and co-investigator of the CIRM project, said in the release.